Skip to main content

Table 4 Postoperative complications and clinical outcomes according to whether osteoporosis was primary or glucocorticoid-induced

From: Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study

 

Primary

GIOP

p-value

Cases, n

132

27

–

Mechanical complications

91 (67.4%)

17 (63.0%)

0.54

 New vertebral fracture

57 (42.8%)

8 (29.6%)

0.21

 Screw complications

54 (39.1%)

7 (25.9%)

0.21

 Screw loosening

42 (30.4%)

5 (18.5%)

0.25

 Screw backout

12 (8.7%)

2 (7.4%)

0.78

 Rod fracture

0

0

–

 Pseudoarthrosis

6 (4.3%)

4 (14.8%)

0.045

Revision due to mechanical complications

17 (12.3%)

2 (7.4%)

0.43

Postoperative JOA

9.7 ± 3.5

8.8 ± 3.0

0.21

Recovery rate of JOA

50.7 ± 27.8

46.1 ± 20.1

0.45

Final VAS (back pain)

30.0 ± 23.7

32.1 ± 20.6

0.74

Change in VAS (back pain)

40.3 ± 30.9

39.4 ± 29.8

0.72

Final VAS (leg pain or numbness)

19.2 ± 22.1

22.3 ± 23.4

0.79

Change in VAS (leg pain or numbness)

34.2 ± 29.0

34.8 ± 23.3

0.99

  1. BP bisphosphonate, TP teriparatide, JOA Japanese Orthopaedic Association, VAS visual analogue scale